We now found that E2F7 was responsible for the repression of miR-15a/16 cluster by competing with E2F1 for binding to the promoter of miR-15a/16 host gene DLEU2 in tamoxifen resistant breast cancer cells. Here, E2F1 is linked to breast carcinoma.